November 01, 2025

Get In Touch

Raid: Rs 4 Crore Seized From Pharma Unit In Chandigarh

Nectar Lifesciences Raid

Nectar Lifesciences Raid

Chandigarh: A pharmaceutical firm, Nectar Lifesciences, was recently raided by a team of the Income Tax Department, wherein Rs 4 crore was seized from its office.

As per a recent report by The Tribune, the raid was carried out in connection with a 'benami' land deal of 117 acres in Indore, Madhya Pradesh on December 13.

I-T sleuths, led by Principal Director LK Aggarwal, Joint Director Ankur Alya, and Deputy Director Robin Bansal, reached the office of Nectar Lifesciences and the house of its MD, Sanjiv Goyal, at 4:30 am on Sunday.

The office of a Sector 9-based pharmaceutical company and its Managing Director's (MD) house was raided by the team. Sources told the daily that the raid had been going on for the past 42 hours.

"Raids are being carried out at the house of the company's key person and its other employees in Delhi and Mumbai too," the sources told The Tribune.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!